Exelon Corporation
—- Market cap
- —
- Debt
- +$51.09B
- Cash
- −$626.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EXC stock price vs EVH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EVH's multiple
Needs Annual EPS, EVH P/E.
Implied fair value · at EXC's multiple
Needs Annual EPS is negative, EXC P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXC FY 2025 (ended Dec 31, 2025) · EVH FY 2025 (ended Dec 31, 2025).
Trendline
Nine fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EXELON CORPORATION · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Evolent Health, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.77x
2.34x
Net debt / EBITDA
Leverage against operating earnings
6.04x
-2.11x
Cash and equivalents
Liquid reserves on the balance sheet
$626.00M
$151.86M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SOUTHERN CO
EXC vs SO
ENTERGY CORP /DE/
EXC vs ETR
CONSOLIDATED EDISON INC
EXC vs ED
Duke Energy Corporation
EXC vs DUK
AMERICAN ELECTRIC POWER CO INC
EXC vs AEP
DOMINION ENERGY, INC
EXC vs D
Cigna Group
EXC vs CI
MOLINA HEALTHCARE, INC.
EXC vs MOH
Teladoc Health, Inc.
EXC vs TDOC
CLOVER HEALTH INVESTMENTS, CORP. /DE
EXC vs CLOV
UNITEDHEALTH GROUP INC
EXC vs UNH
$51.09B
$970.54M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.